Mamoru Kubota - Sysmex Executive Officer

All Insiders USA . 
Stock . Sysmex . Stakeholders . Insider . Mamoru Kubota
SSMXF Stock  USD 20.13  0.00  0.00%   

Executive

Mamoru Kubota is Executive Officer of Sysmex since 2018.
Tenure 6 years
Phone81 78 265 0500
Webhttps://www.sysmex.co.jp

Sysmex Management Efficiency

The company has return on total asset (ROA) of 0.0955 % which means that it generated a profit of $0.0955 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1315 %, meaning that it generated $0.1315 on every $100 dollars invested by stockholders. Sysmex's management efficiency ratios could be used to measure how well Sysmex manages its routine affairs as well as how well it operates its assets and liabilities.
Sysmex has accumulated 23.85 B in total debt with debt to equity ratio (D/E) of 0.07, which may suggest the company is not taking enough advantage from borrowing. Sysmex has a current ratio of 2.82, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Sysmex until it has trouble settling it off, either with new capital or with free cash flow. So, Sysmex's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sysmex sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sysmex to invest in growth at high rates of return. When we think about Sysmex's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Neil WhitfieldRepligen
N/A
Michele PolinskyWest Pharmaceutical Services
N/A
Glenn VavosoIntuitive Surgical
N/A
Brian MillerIntuitive Surgical
N/A
Marshall MohrIntuitive Surgical
68
Christine GebskiRepligen
56
Jaime HumaraRepligen
N/A
John CFAWest Pharmaceutical Services
N/A
Christopher CarlsonIntuitive Surgical
N/A
Keith RobinsonRepligen
N/A
Kola OtitojuRepligen
N/A
Gillian EdDIntuitive Surgical
N/A
Ed McGoughAlcon AG
63
Leslie GalvinRepligen
N/A
Teresa FerragamoRepligen
N/A
Nicholas KhadderThe Cooper Companies,
50
MD FACSIntuitive Surgical
67
Andrea FrohningDentsply Sirona
54
Sarah ComstockMerit Medical Systems
N/A
Daniel CravensAlcon AG
N/A
Andrea DaleyDentsply Sirona
N/A
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan. SYSMEX CORP operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 8771 people. Sysmex [SSMXF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Return On Equity0.13
Return On Asset0.0955

Sysmex Leadership Team

Elected by the shareholders, the Sysmex's board of directors comprises two types of representatives: Sysmex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sysmex. The board's role is to monitor Sysmex's management team and ensure that shareholders' interests are well served. Sysmex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sysmex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kenji Tachibana, Executive VP of Bus. Strategy Devel., Sr. Executive Officer and Member of the Managing Board
Tomokazu Yoshida, Executive Officer
Hisashi Ietsugu, Chairman of the Managing Board, CEO and President Member of Global Strategic Committee, Member of Group Management Reporting Committee and Member of Steering Committee
Takashi Ono, Executive Officer
Kaoru Asano, Sr. Executive Officer, Member of the Managing Board and Director
Kensuke Lizuka, Sr Div
Hiroshi Kanda, Executive Officer
Mitsuhisa Kanagawa, Executive Officer
Iwane Matsui, Executive Officer
Mamoru Kubota, Executive Officer

Sysmex Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sysmex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.13
Return On Asset0.0955
Profit Margin0.11 %
Operating Margin0.18 %
Current Valuation13.3 B
Shares Outstanding209.24 M
Shares Owned By Insiders26.79 %
Shares Owned By Institutions31.37 %
Price To Earning44.34 X
Price To Book4.74 X

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors

Other Information on Investing in Sysmex Pink Sheet

Sysmex financial ratios help investors to determine whether Sysmex Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sysmex with respect to the benefits of owning Sysmex security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY